PayPal's Q2 Beat Falls Flat: Soft Guidance and M&A Silence Weigh on $PYPL
$PYPL beat Q2 earnings but guided soft for Q3, while CEO silence on Stripe talks leaves momentum traders cold.
Coca-Cola Set to Report Q2 Earnings After Strong Year-to-Date Performance
Coca-Cola's YTD performance has outpaced the S&P 500, making its upcoming Q2 earnings report pivotal for investors.
Albertsons Faces Investor Concern as Weak Consumer Spending Forces Outlook Cut
Albertsons (ACI) shares plummet as the company revises its outlook amid declining grocery sales and rising inflation.
TriCo Bancshares Reports Strong Q2 Earnings Amid Merger Announcement
TriCo Bancshares posts Q2 2026 earnings of $34.2 million, highlighted by robust loan growth and a merger announcement.
American Airlines Cuts 2026 Earnings Forecast: Impact of Rising Fuel Costs
American Airlines has revised its 2026 earnings outlook downward due to escalating fuel costs driven by geopolitical tensions.
Netflix Q2 Earnings Preview: Ad Tier Momentum and M&A Signals Could Set the Tone for Streaming in H2 2026
Netflix reports Q2 2026 earnings after hours today. Investors are laser-focused on ad-tier growth and any M&A commentary—results could resha…
UnitedHealth's Q2 Earnings: AI Investments and Margin Recovery Drive Outlook Upgrade
UnitedHealth Group beats Q2 2026 earnings expectations, leading to an upgraded full-year outlook fueled by AI investments.
Financial Giants Report Strong Q2 Earnings: What This Means for Investors
Strong Q2 earnings from major banks signal potential growth for dividend-paying financials amid cooling inflation.
Venture Global's Q2 LNG Liquefaction Fees Jump 69% as Iran War Drives Energy Price Windfall
Venture Global reports a significant increase in Q2 LNG liquefaction fees, attributed to rising global energy prices due to geopolitical ten…
Vertex Pharmaceuticals' $10 Billion Acquisition of Crinetics: What It Means for Investors
Vertex's $10 billion acquisition of Crinetics could reshape its financial landscape, impacting share value and investor sentiment.
United Therapeutics Expands Biotech Horizons with Thymmune Acquisition
United Therapeutics has acquired Thymmune Therapeutics, enhancing its regenerative cell therapy pipeline and strategic positioning.
Hammond Power Solutions Completes CAD $365M Acquisition, Strengthening TSX Presence
Hammond Power Solutions enhances its market position with a CAD $365M acquisition of AEG Power Solutions.